During the past decade, Dongguk University Ilsan Hospital conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 4 clinical trials were completed, i.e. on average, 13.8% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 1 clinical trials were completed. i.e. 6.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dongguk University Ilsan Hospital" #1 sponsor was "Pfizer" with 5 trials, followed by "Asan Medical Center" with 3 trials sponsored, "Hanmi Pharmaceutical Company Limited" with 3 trials sponsored, "Kang Stem Biotech Co., Ltd." with 3 trials sponsored and "Bayer" with 3 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dongguk University Ilsan Hospital" #1 collaborator was "DongGuk University" with 3 trials as a collaborator, "Gyeongsang National University Hospital" with 3 trials as a collaborator, "Asan Medical Center" with 2 trials as a collaborator, "Jeju National University Hospital" with 2 trials as a collaborator and "KangWon National University Hospital" with 2 trials as a collaborator. Other collaborators include 25 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "Dongguk University Ilsan Hospital" are "Atopic Dermatitis" (3 trials), "Hypertension" (3 trials), "Alzheimer's Disease" (2 trials), "Cardiovascular Disease" (2 trials) and "Crohn Disease" (2 trials). Many other conditions were trialed in "Dongguk University Ilsan Hospital" in a lesser frequency.

Most popular intervention types in "Dongguk University Ilsan Hospital" are "Drug" (27 trials), "Device" (5 trials), "Other" (4 trials), "Biological" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Cilostazol" (2 trials), "HCP1803-3" (2 trials), "HPP2003-3" (2 trials) and "Rosuvastatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Dongguk University Ilsan Hospital" are 36 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Dongguk University Ilsan Hospital". 2 are not yet recruiting, 7 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Dongguk University Ilsan Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Dongguk University Ilsan Hospital, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 6 trials that are defined as “Not Applicable".